Ai-Qing Ma

2.9k total citations · 1 hit paper
31 papers, 2.5k citations indexed

About

Ai-Qing Ma is a scholar working on Biomedical Engineering, Oncology and Biomaterials. According to data from OpenAlex, Ai-Qing Ma has authored 31 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Biomedical Engineering, 6 papers in Oncology and 6 papers in Biomaterials. Recurrent topics in Ai-Qing Ma's work include Nanoplatforms for cancer theranostics (20 papers), Cancer Research and Treatments (6 papers) and Nanoparticle-Based Drug Delivery (6 papers). Ai-Qing Ma is often cited by papers focused on Nanoplatforms for cancer theranostics (20 papers), Cancer Research and Treatments (6 papers) and Nanoparticle-Based Drug Delivery (6 papers). Ai-Qing Ma collaborates with scholars based in China and United States. Ai-Qing Ma's co-authors include Lintao Cai, Mingbin Zheng, Ze Chen, Lanlan Liu, Hong Pan, Ruijing Liang, Zhenyu Luo, Ting Yin, Hao Tian and Yifan Ma and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Ai-Qing Ma

31 papers receiving 2.5k citations

Hit Papers

Cancer Cell Membrane–Biomimetic Nanoparticles for Homolog... 2016 2026 2019 2022 2016 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ai-Qing Ma China 19 2.0k 799 776 457 336 31 2.5k
Presley MacMillan Canada 11 1.7k 0.8× 1.5k 1.9× 1.0k 1.4× 467 1.0× 90 0.3× 12 2.8k
Can Xu China 20 1.5k 0.7× 778 1.0× 1.0k 1.3× 859 1.9× 73 0.2× 39 2.7k
Qian‐Fang Meng China 23 1.6k 0.8× 812 1.0× 990 1.3× 304 0.7× 74 0.2× 40 2.3k
Emilia S. Olson United States 14 853 0.4× 485 0.6× 1.3k 1.7× 239 0.5× 139 0.4× 20 2.4k
Zachary P. Lin Canada 11 1.4k 0.7× 1.2k 1.5× 858 1.1× 383 0.8× 76 0.2× 15 2.3k
Guihong Lu China 25 1.5k 0.8× 486 0.6× 743 1.0× 707 1.5× 72 0.2× 39 2.2k
Hunter N. Bomba United States 12 1.6k 0.8× 870 1.1× 893 1.2× 198 0.4× 108 0.3× 24 2.5k
Jinghan Su China 14 1.7k 0.8× 1.2k 1.5× 981 1.3× 323 0.7× 78 0.2× 20 2.2k
Jing‐Jie Ye China 22 1.4k 0.7× 430 0.5× 624 0.8× 489 1.1× 131 0.4× 31 1.8k

Countries citing papers authored by Ai-Qing Ma

Since Specialization
Citations

This map shows the geographic impact of Ai-Qing Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ai-Qing Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ai-Qing Ma more than expected).

Fields of papers citing papers by Ai-Qing Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ai-Qing Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ai-Qing Ma. The network helps show where Ai-Qing Ma may publish in the future.

Co-authorship network of co-authors of Ai-Qing Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Ai-Qing Ma. A scholar is included among the top collaborators of Ai-Qing Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ai-Qing Ma. Ai-Qing Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Guojun, Xiaocong Chen, Ting Yin, et al.. (2024). Bioorthogonal oncolytic-virus nanovesicles combined bio-immunotherapy with CAR-T cells for solid tumors. Biomaterials Science. 13(2). 457–465. 4 indexed citations
2.
Ren, Jian, Ai-Qing Ma, Shida Chen, et al.. (2024). Cyanobacteria-intelligent biohybrid system enables light-guided tumor-associated macrophage-specific siRNA delivery. Cell Reports Physical Science. 5(12). 102301–102301. 2 indexed citations
3.
Huang, Guojun, et al.. (2024). Bioactive-material-programmed CAR-T cell living drug for augmented immunotherapy against tumors. Cell Reports Physical Science. 5(6). 102022–102022. 4 indexed citations
4.
He, Huamei, Ai-Qing Ma, Jian Ren, et al.. (2023). Reconstructing Tumor Microenvironment Using Photoresponsive Cyanobacteria to Reversal Chemoresistance for Robust Chemotherapy. SHILAP Revista de lepidopterología. 4(5). 3 indexed citations
5.
Zhang, Lishan, Baozhen Zhang, Ruijing Liang, et al.. (2023). A Dual-Biomineralized Yeast Micro-/Nanorobot with Self-Driving Penetration for Gastritis Therapy and Motility Recovery. ACS Nano. 17(7). 6410–6422. 33 indexed citations
6.
Yin, Ting, Ai-Qing Ma, Hong Pan, et al.. (2022). Cleavable collagenase-assistant nanosonosensitizer for tumor penetration and sonodynamic therapy. Biomaterials. 293. 121992–121992. 40 indexed citations
8.
Luo, Yingmei, Ze Chen, Mingjian Sun, et al.. (2021). IL-12 nanochaperone-engineered CAR T cell for robust tumor-immunotherapy. Biomaterials. 281. 121341–121341. 91 indexed citations
9.
Yin, Ting, Hui Ran, Yaguang Ren, et al.. (2021). Hypoxia-alleviated sonodynamic therapy based on a hybrid protein oxygen carrier to enhance tumor inhibition. Biomaterials Science. 10(1). 294–305. 30 indexed citations
10.
Chen, Huaqing, Lanlan Liu, Ai-Qing Ma, et al.. (2021). Noninvasively immunogenic sonodynamic therapy with manganese protoporphyrin liposomes against triple-negative breast cancer. Biomaterials. 269. 120639–120639. 122 indexed citations
11.
Yin, Ting, et al.. (2021). Engineering Bacteria and Bionic Bacterial Derivatives with Nanoparticles for Cancer Therapy. Small. 18(12). e2104643–e2104643. 60 indexed citations
12.
Yin, Ting, Shuiming Li, Tiantian Xu, et al.. (2021). Targeted Cancer Therapy: Sequential Magneto‐Actuated and Optics‐Triggered Biomicrorobots for Targeted Cancer Therapy (Adv. Funct. Mater. 11/2021). Advanced Functional Materials. 31(11). 6 indexed citations
13.
He, Huamei, Lanlan Liu, Shengping Zhang, et al.. (2020). Smart gold nanocages for mild heat-triggered drug release and breaking chemoresistance. Journal of Controlled Release. 323. 387–397. 46 indexed citations
14.
Yin, Ting, Shuiming Li, Tiantian Xu, et al.. (2020). Sequential Magneto‐Actuated and Optics‐Triggered Biomicrorobots for Targeted Cancer Therapy. Advanced Functional Materials. 31(11). 103 indexed citations
15.
Chen, Fu-Ming, Ze Chen, Liao Cui, et al.. (2019). Nanophotosensitizer-engineered Salmonella bacteria with hypoxia targeting and photothermal-assisted mutual bioaccumulation for solid tumor therapy. Biomaterials. 214. 119226–119226. 183 indexed citations
16.
Han, Yutong, Hong Pan, Wen‐Jun Li, et al.. (2019). T Cell Membrane Mimicking Nanoparticles with Bioorthogonal Targeting and Immune Recognition for Enhanced Photothermal Therapy. Advanced Science. 6(15). 1900251–1900251. 175 indexed citations
17.
Luo, Zhenyu, Hao Tian, Lanlan Liu, et al.. (2018). Tumor-targeted hybrid protein oxygen carrier to simultaneously enhance hypoxia-dampened chemotherapy and photodynamic therapy at a single dose. Theranostics. 8(13). 3584–3596. 104 indexed citations
18.
Ma, Ai-Qing, Huaqing Chen, Yanhong Cui, et al.. (2018). Metalloporphyrin Complex‐Based Nanosonosensitizers for Deep‐Tissue Tumor Theranostics by Noninvasive Sonodynamic Therapy. Small. 15(5). e1804028–e1804028. 215 indexed citations
20.
Ma, Ai-Qing, et al.. (2006). (E)-4,4′-Diazastilbene–4,4′-oxydibenzoic acid (1/1). Acta Crystallographica Section E Structure Reports Online. 62(3). o1165–o1166. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026